D-0012-2027 Class II Ongoing
FDA drug recall D-0012-2027 was initiated by BioSpectra, Inc. on Jul 29, 2026 and is designated Class II. Reason for recall: Failed stability specifications The recall status is ongoing. Affected quantity: 200 kg.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 14, 2026
- Initiation Date
- Jul 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 200 kg
Product description
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
Reason for recall
Failed stability specifications
Distribution pattern
CA
Code information
Lot#: TRIS -E04-0226-0016; Exp 2/29/28
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0012-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026